CN113940899B - 一种防水粉底组合物及其制备方法 - Google Patents
一种防水粉底组合物及其制备方法 Download PDFInfo
- Publication number
- CN113940899B CN113940899B CN202111155696.1A CN202111155696A CN113940899B CN 113940899 B CN113940899 B CN 113940899B CN 202111155696 A CN202111155696 A CN 202111155696A CN 113940899 B CN113940899 B CN 113940899B
- Authority
- CN
- China
- Prior art keywords
- water
- oil
- percent
- agent
- foundation composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 45
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 44
- 239000003921 oil Substances 0.000 claims abstract description 42
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 33
- 239000000725 suspension Substances 0.000 claims abstract description 17
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000004519 grease Substances 0.000 claims abstract description 14
- 239000003906 humectant Substances 0.000 claims abstract description 13
- 239000002562 thickening agent Substances 0.000 claims abstract description 13
- 239000003086 colorant Substances 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 9
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 8
- 238000003756 stirring Methods 0.000 claims description 21
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 18
- 229920001577 copolymer Polymers 0.000 claims description 18
- 150000002148 esters Chemical class 0.000 claims description 15
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 14
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 14
- 230000003750 conditioning effect Effects 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 6
- 239000002738 chelating agent Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical group OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 230000003472 neutralizing effect Effects 0.000 claims description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 4
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 4
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 3
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 3
- 229960000458 allantoin Drugs 0.000 claims description 3
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 3
- 229940036350 bisabolol Drugs 0.000 claims description 3
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 3
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 3
- 229940042585 tocopherol acetate Drugs 0.000 claims description 3
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical group CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical group OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims 1
- 229940008099 dimethicone Drugs 0.000 claims 1
- CNXJITYCNQNTBD-UHFFFAOYSA-L dipotassium;hexadecyl phosphate Chemical group [K+].[K+].CCCCCCCCCCCCCCCCOP([O-])([O-])=O CNXJITYCNQNTBD-UHFFFAOYSA-L 0.000 claims 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 5
- 210000004243 sweat Anatomy 0.000 abstract description 5
- 230000002045 lasting effect Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 30
- 239000000047 product Substances 0.000 description 18
- -1 linolenyl carbonate Chemical compound 0.000 description 13
- 238000012360 testing method Methods 0.000 description 11
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 9
- 238000004945 emulsification Methods 0.000 description 8
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 229920006037 cross link polymer Polymers 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000007547 defect Effects 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 229940072106 hydroxystearate Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- LOXVSKUQULMRNO-HVDRVSQOSA-N N[C@@H](CCC(N)=O)C(=O)O.C(CCCCCCCCCCC)(=O)N Chemical compound N[C@@H](CCC(N)=O)C(=O)O.C(CCCCCCCCCCC)(=O)N LOXVSKUQULMRNO-HVDRVSQOSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- 241001424341 Tara spinosa Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- TVFJAZCVMOXQRK-UHFFFAOYSA-N ethenyl 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC(=O)OC=C TVFJAZCVMOXQRK-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 1
- GQEZCXVZFLOKMC-UHFFFAOYSA-N n-alpha-hexadecene Natural products CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- LWBVAHQZGAKXPU-BOXHHOBZSA-M sodium;(4s)-4-amino-5-octadecoxy-5-oxopentanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOC(=O)[C@@H](N)CCC([O-])=O LWBVAHQZGAKXPU-BOXHHOBZSA-M 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
本发明提供了一种防水粉底组合物及其制备方法,防水组合物包含以下重量百分含量的组分:悬浮增稠剂3~5%、水性成膜剂0.05~0.2%、水包油乳化剂0.1~0.3%、保湿剂10~15%,油性成膜剂0.5~2%、油包水乳化剂2~4%、油脂3~7%、二氧化钛6~10%、着色剂0~1%。本发明防水粉底组合物抗水性能优异且肤感清爽。在使用涂抹过程中,清爽水润,容易铺展,且当遇到天气、环境和自身汗液影响时,形成的亲水性和亲油性双层薄膜对皮肤进行双重有效保护,从而达到防水和妆效持久的效果。
Description
技术领域
本发明属于化妆品技术领域,具体涉及一种防水粉底组合物及其制备方法。
背景技术
粉底液是面部美容化妆品当中的一种,呈现形态有粉体的水包油形(O/W)或者油包水形(W/O),是一种添加了粉料的乳液状化妆品,主要是利用粉质颜料与甘油和水的相容性好这一特点而制。色调应为较浅的肉色或略带润湿外观的淡珠光色调,随着潮流变化和不同的民族习惯,半透明程度、颜色的深浅和类型、其他外观特性都有较大差异。它在表面形成平滑的覆盖层,用以遮盖或掩饰一些面部瑕疵,如雀斑、粉刺、疤痕等,调整皮肤质地、颜色和光泽,起到均匀肤色的作用,使肤色看起来自然贴切,还拥有滑嫩的感觉,具有易涂抹,分布均匀,具有自然外观的特点。
目前粉底的产品主要分为水包油或油包水,水包油的底妆较轻透,但却容易因流汗而脱妆;而油包水的底妆则是目前市场较使用的剂型,因为耐汗耐水性较强,不过缺点是较油腻。油包水型产品在抗水方面虽然明显优于水包油型产品,尤其在油包水型产品中加入成膜剂后,随着成膜剂量的加大其抗水能力逐步加强,但油包水型产品的缺点也很明显,其肤感厚重油腻,使用时难以涂抹铺展,需要较高用量才能在皮肤上全面铺展成膜,尤其在加入成膜剂后其缺点表现得更为明显。即便后续原料制造商开发了诸多硅油包水以及聚甘油酯类乳化体系,其制成产品虽在涂抹感上有所改观,但仍不能达到人们所期望的日常习惯使用的水包油和悬浮体系的涂抹感觉。
随着乳化技术的逐步深入,多重乳化、液晶乳化、α-gel结构乳化以及悬浮等技术也逐步得到开发和应用。多重乳化、液晶乳化以及α-gel结构乳化体都可简单地归为多重乳化体系,其抗水能力虽优于普通水包油型,但制造时相对繁琐,技术和工艺要求较高,在遇水或汗液时将会发生多次反复再乳化,该过程随着雨水或汗液的流淌其有益成分也会流失,从而影响整体产品的预期效果。悬浮体系中悬浮增稠剂可以将油相稳定地悬浮增稠而制成为均一体系。但在皮肤表皮上形成的薄膜,从微观上看并不均匀,由于水分的挥发和皮肤自身沟壑,最终在皮肤表层形成的是一张不完整的蜘蛛网状膜,底妆和彩妆产品出现浮粉、卡粉和花妆等现象。
发明内容
本发明的目的在于克服现有技术存在的不足之处而提供一种防水粉底组合物及其制备方法。
为实现上述目的,本发明采取的技术方案为:
第一方面,本发明提供一种防水粉底组合物,包含以下重量百分含量的组分:悬浮增稠剂2~5%、水性成膜剂0.05~0.2%、水包油乳化剂0.1~0.3%、保湿剂10~15%,油性成膜剂0.5~2%、油包水乳化剂2~4%、油脂3~7%、二氧化钛6~10%、着色剂0~1%。
本发明通过将较高含量的油包水乳化剂添加到悬浮体系中,制得一种易于涂抹且防水性能好的粉底组合物,配方中还加入了少量水包油乳化剂,由于油包水乳化剂含量远远高于水包油乳化剂,所以不会影响油包水体系的形成,而且进一步增强了清爽水润的肤感,同时,使产品在涂抹后,细腻均匀。同时,配方中还含有水性成膜剂和油性成膜剂,水性成膜剂的添加有助于短时涂抹时水性膜的形成,使短时涂抹过程的涂抹感跟悬浮体系涂抹肤感基本一致。由于皮肤的亲脂性,油性成膜剂的添加使涂抹过程中油酯自身就较容易在皮肤上进行均匀铺展,但成膜剂的加入将会使油膜变得更为坚实和持久,进而达到更好的抗水和持妆能力。二氧化钛及着色剂为粉底组合物带来遮瑕、防晒、修正肤色等效果。
优选地,所述防水粉底组合物,包含以下重量百分含量的组分:悬浮增稠剂4%、水性成膜剂0.1%、水包油乳化剂0.2%、保湿剂10~15%,油性成膜剂1%、油包水乳化剂3%、油脂4~6%、二氧化钛6~10%、着色剂0~1%。
发明人通过研究发现,本发明中各组分在上述重量百分含量下,具有较佳的涂抹肤感及防水效果。
悬浮增稠剂是本发明的基础体系,悬浮增稠剂选用丙烯酸(酯)类共聚物、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物、丙烯酸(酯)类/山嵛醇聚醚-25甲基丙烯酸酯共聚物、丙烯酸(酯)类/硬脂醇聚醚-20甲基丙烯酸酯共聚物、聚丙烯酸酯-1、丙烯酸(酯)类/新癸酸乙烯酯交联聚合物、丙烯酸(酯)类/硬脂醇聚醚-20甲基丙烯酸酯共聚物、丙烯酸(酯)类/硬脂醇聚醚-20衣康酸酯共聚物、丙烯酰二甲基牛磺酸铵/VP共聚物、丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物中的至少一种。本发明优选丙烯酸(酯)类共聚物作为悬浮增稠剂。
水性成膜剂选用聚乙烯吡咯烷酮、VP/丙烯酸(酯)类/月桂醇甲基丙烯酸酯共聚物、聚乙烯醇、刺云实胶中的至少一种。本发明优选聚乙烯吡咯烷酮作为水性成膜剂。
水包油乳化剂选用鲸蜡醇磷酸酯钾、硬脂酰谷氨酸钠、二(月桂酰胺谷氨酰胺)赖氨酸钠、C20-22醇磷酸酯、硬脂醇聚醚-21、聚甘油-3甲基葡糖二硬脂酸酯、鲸蜡硬脂基葡糖苷、氢化卵磷脂中的至少一种。本发明优选鲸蜡醇磷酸酯钾作为水包油乳化剂。
油性成膜剂选用三甲基硅烷氧基硅酸酯、丙烯酸(酯)类/聚二甲基硅氧烷共聚物、VP/十六碳烯共聚物、VP/二十碳烯共聚物、氢化二聚亚油醇碳酸酯/碳酸二甲酯共聚物、聚甲基倍半硅氧烷、乙烯基聚二甲基硅氧烷/聚甲基硅氧烷倍半硅氧烷交联聚合物中的至少一种。本发明优选丙烯酸(酯)类/聚二甲基硅氧烷共聚物作为油性成膜剂。
油包水乳化剂选用山梨坦异硬脂酸酯、山梨坦油酸酯、山梨坦倍半油酸酯、PEG-10聚二甲基硅氧烷、鲸蜡基PEG/PPG-10/1聚二甲基硅氧烷、月桂基PEG-8聚二甲基硅氧烷、月桂基PEG-9聚二甲基硅氧乙基聚二甲基硅氧烷、月桂基PEG/PPG-18/18聚甲基硅氧烷、月桂基PEG-10三(三甲基硅氧基)硅乙基聚甲基硅氧烷、聚二甲基硅氧烷PEG-10/15交联聚合物、聚甘油-3蓖麻醇酸酯、聚甘油-10二油酸酯、聚甘油-2二聚羟基硬脂酸酯、聚甘油-3二异硬脂酸酯、PEG-30二聚羟基硬脂酸酯、硬脂醇聚醚-2、甲基葡糖倍半硬脂酸酯、甘油硬脂酸酯中的至少一种。本发明优选山梨坦倍半油酸酯作为油包水乳化剂。
优选地,所述悬浮增稠剂为丙烯酸(酯)类共聚物,所述水性成膜剂为聚乙烯吡咯烷酮,所述水包油乳化剂为鲸蜡醇磷酸酯钾,所述油性成膜剂为丙烯酸(酯)类/聚二甲基硅氧烷共聚物,所述油包水乳化剂为山梨坦倍半油酸酯。
优选地,所述保湿剂包含分别占所述防水粉底组合物重量8~12%的甘油、0~2%的乙二醇、2~4%的丙二醇。
优选地,以所述防水粉底组合物的总重量为基准计,甘油占10%、乙二醇占1%、丙二醇占3%。
优选地,所述防水粉底组合物还包含重量百分比含量为0~1%的皮肤调理剂。所述皮肤调理剂包含分别占所述防水粉底组合物重量0~0.5%的尿囊素、0~0.05%的透明质酸钠、0~0.35%的维生素E醋酸酯、0~0.5%的红没药醇、0~0.1%的甘草酸二钾。
发明人通过研究发现,保湿剂及皮肤调理剂的加入有效提高皮肤角质层水分含量,提升产品使用效果。
优选地,以所述防水粉底组合物的总重量为基准计,尿囊素占0.1%、透明质酸钠占0.01%、维生素E醋酸酯占0.07%、红没药醇占0.1%、甘草酸二钾占0.05%。
优选地,所述油脂包含分别占所述防水粉底组合物重量2~4%的氢化聚异丁烯和1~3%的环五聚二甲基硅氧烷。
油脂的添加有助于产品的长期稳定,也有助于提高产品后期形成膜的强度。
优选地,所述防水粉底组合物还包含重量百分含量比含量为0.01~0.03%的螯合剂、0.3~0.7%的防腐剂、0.3~0.7%的中和剂和0~0.2%的香精。
第二方面,本发明还提供上述防水粉底组合物的制备方法,包含以下步骤:
(1)将悬浮增稠剂、水性成膜剂、螯合剂、防腐剂、70~80wt%保湿剂和0~40wt%皮肤调理剂加热升温至80℃,搅拌均匀,降温至40℃,然后加入40~60wt%中和剂,搅拌均匀,然后加入水包油乳化剂、20~30wt%保湿剂和0~25wt%皮肤调理剂,搅拌溶解完全,得到水相;
(2)将着色剂、二氧化钛、油包水乳化剂、20~50wt%皮肤调理剂和40~60wt%油脂混合均匀,再加入油相成膜剂、40~60wt%油脂,搅拌均匀,得到油相;
(3)在搅拌状态下,将油相加入水相中,搅拌均匀后,加入香精,然后加入40~60%中和剂,搅拌至均匀增稠,得到所述防水粉底组合物。
本发明组合物中没有难溶成分,整个制作过程只需加温搅拌,适当匀质效果更佳,制备工艺简单,从而达到很好的节能环保作用。
本发明的有益效果在于:本发明提供了一种抗水性能优异且肤感清爽的防水粉底组合物。在使用涂抹过程中,清爽水润,容易铺展,且当遇到天气、环境和自身汗液影响时,形成的亲水性和亲油性双层薄膜对皮肤进行双重有效保护,从而达到防水和妆效持久的性能。
具体实施方式
为更好的说明本发明的目的、技术方案和优点,下面将结合具体实施例对本发明作进一步说明。
本发明提供一种防水粉底组合物及其制备方法。
实施例1~5为本发明一种防水粉底组合物的实施例,实施例1~5的成分以及重量百分比含量见表1所示:
表1
实施例1~5的防水粉底组合物的制备方法,包括以下步骤:
(1)将悬浮增稠剂、水性成膜剂、螯合剂、防腐剂、70~80wt%保湿剂和0~40wt%皮肤调理剂加热升温至80℃,搅拌均匀,降温至40℃,然后加入40~60wt%中和剂,搅拌均匀,然后加入水包油乳化剂、20~30wt%保湿剂和0~25wt%皮肤调理剂,搅拌溶解完全,得到水相;
(2)将着色剂、二氧化钛、油包水乳化剂、20~50wt%皮肤调理剂和40~60wt%油脂混合均匀,再加入油相成膜剂、40~60wt%油脂,搅拌均匀,得到油相;
(3)在搅拌状态下,将油相加入水相中,搅拌均匀后,加入香精,然后加入40~60wt%中和剂,搅拌至均匀增稠,得到所述防水粉底组合物。
对比例1~7
对比例1~7的防水粉底组合物成分以及重量百分含量见表2所示:
表2
对比例1~7的防水粉底组合物的制备方法与实施例1相同。
效果例1:防水性能测试。
测试方法:将实施例1-5和对比例1-7制备的防水粉底通过拉膜器在德国BYK的拉膜板上拉制成60μm厚度的均匀薄膜。自然晾干后,用KRUSS DSA25液滴形状分析仪进行接触角测试,进而评判不同样板的疏水能力。该实验温度为25℃,采用生理盐水作为接触液体,一个样品至少取3个点进行接触角(CA)测试,测试结果取其平均值。接触角的采集数据均为液滴滴落后1s的数据,滴落液滴体积为3.5μL,接触角(CA)测试结果见表3。静态接触角越大,防水效果越好。
表3防水测试结果
组别 | 接触角(CA)/度 | 组别 | 接触角(CA)/度 |
实施例1 | 76.8 | 对比例1 | 77.2 |
实施例2 | 74.6 | 对比例2 | 73.4 |
实施例3 | 77.9 | 对比例3 | 76.5 |
实施例4 | 77.5 | 对比例4 | 62.3 |
实施例5 | 72.1 | 对比例5 | 76.3 |
对比例6 | 73.8 | 对比例7 | 78.4 |
从表3中的实验结果可以看出,实施例1-5和对比例中(除对比例4外)的静态接触角均大于72°,而对比例4只含有水包油乳化剂而不含有油包水乳化剂,其静态接触角相对较小为62.3°,对比例1中无悬浮剂,体系最终形成油包水体系,接触角较大为77.2°,对比例2和6中分别不添加水性成膜剂和油性成膜剂其接触角有少许减小,对比例3和5中油脂种类和添加量的变化对最终产品接触角影响较小。
效果例2:肤感测试。
根据化妆品行业内感官分析法,对实施例1-5和对比例1-7水润粉底进行肤感评价。
(1)评价项目:铺展性、水润感、吸收性、总体评分;
(2)评分制度:各项指标的最高分为10分,表示非常好;8分是比较好;6分是可以接受;6分以下为不可接受的范围。
(3)方法:选取35位受过培训的评估人员,女性,年龄25-35岁;盲测进行评分,最终取其平均得分。测试结果见表4。
表4肤感测试结果
组别 | 铺展性 | 水润感 | 吸收性 | 贴服性 | 持久 | 总体评分 |
实施例1 | 7.9 | 7.8 | 8.0 | 8.6 | 8.7 | 8.2 |
实施例2 | 8.5 | 8.3 | 8.5 | 9.1 | 8.3 | 8.5 |
实施例3 | 8.1 | 7.6 | 8.3 | 8.9 | 8.7 | 8.3 |
实施例4 | 7.8 | 7.4 | 7.9 | 8.4 | 8.9 | 8.1 |
实施例5 | 7.6 | 6.4 | 7.7 | 8.7 | 9.5 | 8.0 |
对比例1 | 6.2 | 5.0 | 7.0 | 8.5 | 9.1 | 7.2 |
对比例2 | 8.3 | 7.5 | 8.2 | 8.0 | 8.4 | 8.0 |
对比例3 | 7.2 | 7.4 | 7.5 | 8.1 | 8.5 | 7.8 |
对比例4 | 7.3 | 8.1 | 7.2 | 6.5 | 7.4 | 7.3 |
对比例5 | 7.3 | 7.2 | 7.3 | 8.3 | 8.6 | 7.7 |
对比例6 | 8.0 | 7.5 | 7.6 | 7.3 | 7.8 | 7.6 |
对比例7 | 7.0 | 7.3 | 7.4 | 8.1 | 8.5 | 7.7 |
从表4可知,对比例1不含悬浮剂,整个体系后期形成油包水型产品,涂抹感变差,对比例2和6分别不含有水性成膜剂和油性成膜剂,在产品持久和贴服性上有所下降,对比例3和5不同种类油脂的减少对产品后期的铺展性有所降低,对比例4不加油包水乳化剂时,涂抹时成油水分离状态,产品贴服性和吸收性有较大影响,对比例7不加水包油乳化剂,在铺展性和吸收性方面有所影响。而实施例1-3从油包水乳化剂含量看,随着油包水乳化剂的提高,接触角有所降低,但区别较小;综合表3和表4结果,油包水乳化剂在该粉底体系中含量在1%-3%时,区别不明显。
最后所应当说明的是,以上实施例仅用以说明本发明的技术方案而非对本发明保护范围的限制,尽管参照较佳实施例对本发明作了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的实质和范围。
Claims (2)
1.一种防水粉底组合物,其特征在于,由以下重量百分含量的组分组成:悬浮增稠剂4%、水性成膜剂0.1%、水包油乳化剂0.2%、保湿剂13.5%,油性成膜剂1%、油包水乳化剂3%、油脂5%、二氧化钛8%、着色剂0.69%、皮肤调理剂0.33%、螯合剂0.02%、防腐剂0.5%、中和剂0.5%、香精0.1%,余量为水;
所述皮肤调理剂为分别占所述防水粉底组合物重量0.1%的尿囊素、0.01%的透明质酸钠、0.07%的维生素E醋酸酯、0.1%的红没药醇和0.05%的甘草酸二钾;
所述螯合剂为EDTA-2NA;所述防腐剂为对羟基苯乙酮;所述中和剂为三乙醇胺;
所述保湿剂为分别占所述防水粉底组合物重量10%的甘油、0.5%的己二醇和3%的丙二醇;
所述油脂为分别占所述防水粉底组合物重量3%的氢化聚异丁烯和2%的环五聚二甲基硅氧烷;
所述着色剂为分别占所述防水粉底组合物重量0.01%的CI77499、0.5%的CI77492和0.18%的CI77491;
所述悬浮增稠剂为丙烯酸(酯)类共聚物,所述水性成膜剂为聚乙烯吡咯烷酮,所述水包油乳化剂为鲸蜡醇磷酸酯钾,所述油性成膜剂为丙烯酸(酯)类/聚二甲基硅氧烷共聚物,所述油包水乳化剂为山梨坦倍半油酸酯。
2.一种如权利要求1所述的防水粉底组合物的制备方法,其特征在于,包含以下步骤:
(1)将悬浮增稠剂、水性成膜剂、螯合剂、防腐剂、70~80wt%保湿剂和0~40wt%皮肤调理剂加热升温至80℃,搅拌均匀,降温至40℃,然后加入40~60wt%中和剂,搅拌均匀,然后加入水包油乳化剂、20~30wt%保湿剂和0~25wt%皮肤调理剂,搅拌溶解完全,得到水相;
(2)将着色剂、二氧化钛、油包水乳化剂、20~50wt%皮肤调理剂和40~60wt%油脂混合均匀,再加入油相成膜剂、40~60wt%油脂,搅拌均匀,得到油相;
(3)在搅拌状态下,将油相加入水相中,搅拌均匀后,加入香精,然后加入40~60 wt %中和剂,搅拌至均匀增稠,得到所述防水粉底组合物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111155696.1A CN113940899B (zh) | 2021-09-29 | 2021-09-29 | 一种防水粉底组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111155696.1A CN113940899B (zh) | 2021-09-29 | 2021-09-29 | 一种防水粉底组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113940899A CN113940899A (zh) | 2022-01-18 |
CN113940899B true CN113940899B (zh) | 2024-03-12 |
Family
ID=79329373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111155696.1A Active CN113940899B (zh) | 2021-09-29 | 2021-09-29 | 一种防水粉底组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113940899B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112656711B (zh) * | 2020-12-18 | 2022-09-20 | 上海中翊日化有限公司 | 一种可放置悬浮物的透明修护唇釉及其制备方法 |
CN114732767A (zh) * | 2022-04-15 | 2022-07-12 | 上海臻臣化妆品有限公司 | 粉底液及其制备方法 |
CN115282071A (zh) * | 2022-07-12 | 2022-11-04 | 广州那比昂生物科技有限公司 | 一种防水烤粉及其制备方法 |
CN115869216A (zh) * | 2022-12-21 | 2023-03-31 | 娇时日化(杭州)股份有限公司 | 一种耐汗粉底液及其制备方法 |
CN116350552B (zh) * | 2023-01-09 | 2023-08-29 | 植物医生(广东)生物科技有限公司 | 一种舒缓、抗衰面霜及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106176302A (zh) * | 2016-08-15 | 2016-12-07 | 广州澳希亚实业有限公司 | 一种转相防晒组合物及其制备方法 |
CN109602643A (zh) * | 2018-12-10 | 2019-04-12 | 广州玮弘祺生物科技有限公司 | 一种bb霜及其制备方法 |
CN110339146A (zh) * | 2019-08-21 | 2019-10-18 | 广州臻颜化妆品有限公司 | 一种水包油包水粉底液及其制备方法 |
KR102058337B1 (ko) * | 2018-08-08 | 2019-12-23 | 코스맥스 주식회사 | 전상유화 방법을 이용한 색조 화장료 조성물의 제조방법 및 이로부터 제조된 색조 화장료 조성물 |
CN113081902A (zh) * | 2021-04-16 | 2021-07-09 | 东晟源研究院(广州)有限公司 | 一种持妆保湿水粉霜及其制备方法 |
CN113350228A (zh) * | 2021-06-28 | 2021-09-07 | 广州卡迪莲化妆品科技有限公司 | 一种能够改善底妆暗沉的妆前乳 |
-
2021
- 2021-09-29 CN CN202111155696.1A patent/CN113940899B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106176302A (zh) * | 2016-08-15 | 2016-12-07 | 广州澳希亚实业有限公司 | 一种转相防晒组合物及其制备方法 |
KR102058337B1 (ko) * | 2018-08-08 | 2019-12-23 | 코스맥스 주식회사 | 전상유화 방법을 이용한 색조 화장료 조성물의 제조방법 및 이로부터 제조된 색조 화장료 조성물 |
CN109602643A (zh) * | 2018-12-10 | 2019-04-12 | 广州玮弘祺生物科技有限公司 | 一种bb霜及其制备方法 |
CN110339146A (zh) * | 2019-08-21 | 2019-10-18 | 广州臻颜化妆品有限公司 | 一种水包油包水粉底液及其制备方法 |
CN113081902A (zh) * | 2021-04-16 | 2021-07-09 | 东晟源研究院(广州)有限公司 | 一种持妆保湿水粉霜及其制备方法 |
CN113350228A (zh) * | 2021-06-28 | 2021-09-07 | 广州卡迪莲化妆品科技有限公司 | 一种能够改善底妆暗沉的妆前乳 |
Also Published As
Publication number | Publication date |
---|---|
CN113940899A (zh) | 2022-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113940899B (zh) | 一种防水粉底组合物及其制备方法 | |
CN111643401B (zh) | 一种高含水量的口红及其制备方法 | |
CN110302094B (zh) | 一种高光泽的不沾杯唇釉及其制备方法 | |
CN108888524B (zh) | 遮瑕组合物及其制备方法 | |
WO2005094775A1 (de) | Zubereitung in form einer emulsion mit einer filmbildenden polymerkombination | |
CN114224753A (zh) | 一种油包水型乳化组合物、粉底液及其制备方法 | |
KR101794555B1 (ko) | 천연 세라마이드 및 로즈힙열매 오일을 유효성분으로 함유하는 입술 보호용 화장료 조성물 | |
CN113679622A (zh) | 一种立体烤粉哑光腮红及其制备方法 | |
KR101227822B1 (ko) | 마스카라 화장료 조성물 | |
CN111588653B (zh) | 一种粉底液及其制备方法 | |
CN111012708B (zh) | 一种粉底液及其制备方法 | |
JP2000063261A (ja) | 皮膚外用剤 | |
CN114425025B (zh) | 一种粉霜哑光唇釉及其制备方法 | |
CN110251417A (zh) | 控油修复妆前精华乳及其制备方法 | |
CN109453067A (zh) | 一种臻颜清润面霜及其制备方法 | |
CN110721097B (zh) | 一种油包水凝霜及其制备方法和用途 | |
CN110215413A (zh) | 一种双凝胶体系的眼唇卸妆凝露化妆品及制备方法 | |
JPH0465047B2 (zh) | ||
CN106580758A (zh) | 一种控油水凝乳及其制备方法 | |
CN111712224A (zh) | 提高了持久力且改善了干燥感的油包水型化妆料组合物 | |
JP3881607B2 (ja) | 化粧料 | |
CN112932989A (zh) | 一种蚕丝蛋白滋润粉底液及其制备方法 | |
CN113768824B (zh) | 一种水性腮红及其制备方法 | |
CN113081872A (zh) | 一种滋润持久口红 | |
CN109745243B (zh) | 一种口红以及制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |